A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Condition: Stem Cell Transplantation Intervention: Sponsor: Bristol-Myers Squibb Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abatacept | Methotrexate | Orencia | Research | Stem Cell Therapy | Stem Cells | Study | Transplants